Treatment FAQ

what is the mechanism of action for hydroxyurea treatment for sickle cell disease patients?

by Helen Bogan Published 3 years ago Updated 2 years ago
image

Although the exact mechanism of action in sickle cell anemia is not completely understood, it is believed that hydroxyurea works by increasing the production of fetal hemoglobin in red blood cells. This may prevent the cells from becoming rigid and clogging the blood vessels.

Hydroxyurea makes your red blood cells bigger. It helps them stay rounder and more flexible — and makes them less likely to turn into a sickle shape. The medicine does this by increasing a special kind of hemoglobin called hemoglobin F.

Full Answer

Does hydroxyurea reduce crisis rates in sickle cell anemia?

The primary and most well understood mechanism of action of hydroxyurea in vivo is the reversible inhibition of ribonucleotide reductase (RR), a critical enzyme that converts ribonucleosides into deoxyribonucleosides, which are required for the synthesis and repair of DNA .

How does hydroxyurea work?

In a randomized, placebo-controlled clinical trial, treatment with hydroxyurea (HU) reduced crisis rates in adult patients with severe sickle cell anemia. No serious acute toxicity was seen, but the safety of long-term therapy could not be evaluated. The rationale for the use of HU was based on its ability to increase fetal hemoglobin (HbF) synthesis and the inhibitory effect of HbF on …

What is the synergy between hydroxyurea and other chemotherapeutic agents?

Feb 05, 2021 · The drug, quite frankly, has myriad benefits to children and adults with sickle cell disease. The mechanism of actions include the inhibition of ribonucleotide reductase, which inhibits reticulocyte production. It’s myelosuppressive, so you get a …

Does hydroxyurea therapy require HbF induction?

How can hydroxyurea help with sickle cell disease? Hydroxyurea reduces the problems that sickle cell disease causes. People with sickle cell disease who take hydroxyurea have fewer: • Pain crises • Episodes of acute chest syndrome • Blood transfusions • Hospital stays Hydroxyurea can also prevent or slow down damage to your organs.

image

What is the mechanism of action of hydroxyurea?

Mechanism of Action Hydroxyurea is a potent RR inhibitor that reduces intracellular deoxynucleotide triphosphate pools and acts as an S-phase-specific agent with inhibition of DNA synthesis and eventual cellular cytotoxicity.

What does hydroxyurea do to the body?

Hydroxyurea is in a class of medications called antimetabolites. Hydroxyurea treats cancer by slowing or stopping the growth of cancer cells in your body. Hydroxyurea treats sickle cell anemia by helping to prevent formation of sickle-shaped red blood cells.

How does hydroxyurea increase hemoglobin F?

Hydroxyurea induces fetal hemoglobin by the nitric oxide–dependent activation of soluble guanylyl cyclase.

When is hydroxyurea used for sickle cell?

We consider hydroxyurea for children with sickle cell disease who have had: Many painful events, • Several cases of acute chest syndrome (pneumonia), • Severe anemia, or • Other special problems with their internal organs.

How does hydroxyurea work in polycythemia vera?

Hydroxyurea is a cancer drug that slows down the growth of new cells in your body. In PV, it lowers the number of red blood cells and platelets, which are cells that help blood clot. If you take this drug, you may not need a treatment called phlebotomy.

How is hydroxyurea administered?

Swallow the capsule or tablet whole. Do not crush, break, chew, or open it. If you cannot swallow the tablet whole, you may dissolve it with a small quantity of water in a teaspoon for about 1 minute. Swallow the mixture right away, then drink a glass of water.Feb 1, 2022

Why does sickle cell increase HbF?

The pathophysiology of sickle cell disease is dependent on the polymerization of deoxy sickle hemoglobin. Increased levels of HbF retard this process. HbF reduces HbS concentration, but more importantly, both HbF and its mixed hybrid tetramer (α2βSγ) cannot enter the deoxy sickle hemoglobin polymer phase.

What is the role of fetal hemoglobin in sickle cell disease?

Fetal hemoglobin (HbF) modulates the phenotype of sickle cell anemia by inhibiting deoxy sickle hemoglobin (HbS) polymerization. The blood concentration of HbF, or the number of cells with detectable HbF (F-cells), does not measure the amount of HbF/F-cell.Jan 23, 2014

Why would increasing the synthesis of HbF alleviate the symptoms of sickle cell anemia?

The high levels of HbF in SCD patients may suggest that increased foetal haemoglobin concentrations may have beneficial effects in SCD22,24This is because increased cellular levels of HbF reduces the tendency of deoxygenated HbS to polymerize since HbF interferes with the intracellular polymerization of HbS42.

How does hydroxyurea inhibit DNA synthesis?

Hydroxyurea is commonly thought to inhibit ongoing DNA replication indirectly by targeting the class Ia ribonucleotide reductase (nrdAB gene products) of E. coli and depleting the dNTP pools required for DNA synthesis to occur (5, 6, 10).

When was hydroxyurea approved?

Hydroxyurea is a medicine that doctors have used to treat people with sickle cell disease since the 1980s. The Food and Drug Administration (FDA) approved it for treating adults with sickle cell disease in 1998. In 2017, the FDA approved it to treat children with sickle cell disease.

Does hydroxurea help sickle cell disease?

Hydroxyurea can help people with sickle cell disease have fewer pain crises and better health. If you have sickle cell disease, it could help you. We hope this booklet has answered some of your questions about this treatment option.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9